Marksans Pharma consolidated net profit rises 169.50% in the June 2026 quarter

Sales rise 35.62% to Rs 840.80 crore

Net profit of Marksans Pharma rose 169.50% to Rs 157.17 crore in the quarter ended June 2026 as against Rs 58.32 crore during the previous quarter ended June 2025. Sales rose 35.62% to Rs 840.80 crore in the quarter ended June 2026 as against Rs 619.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	840.80	619.99	36
OPM %	25.34	16.15	-
PBDT	231.44	99.70	132
PBT	206.57	76.60	170
NP	157.17	58.32	169

Powered by Capital Market - Live News